Literature DB >> 18273623

Animal models of Parkinson's disease progression.

Gloria E Meredith1, Patricia K Sonsalla, Marie-Francoise Chesselet.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder whose etiology is not understood. This disease occurs both sporadically and through inheritance of single genes, although the familial types are rare. Over the past decade or so, experimental and clinical data suggest that PD could be a multifactorial, neurodegenerative disease that involves strong interactions between the environment and genetic predisposition. Our understanding of the pathophysiology and motor deficits of the disease relies heavily on fundamental research on animal models and the last few years have seen an explosion of toxin-, inflammation-induced and genetically manipulated models. The insight gained from the use of such models has strongly advanced our understanding of the progression and stages of the disease. The models have also aided the development of novel therapies to improve symptomatic management, and they are critical for the development of neuroprotective strategies. This review critically evaluates these in vivo models and the roles they play in mimicking the progression of PD.

Entities:  

Mesh:

Year:  2008        PMID: 18273623      PMCID: PMC2562277          DOI: 10.1007/s00401-008-0350-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  137 in total

1.  Pesticide exposure and risk for Parkinson's disease.

Authors:  Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

2.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.

Authors:  Francesco Fornai; Oliver M Schlüter; Paola Lenzi; Marco Gesi; Riccardo Ruffoli; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Fabrizio Pontarelli; Giuseppe Battaglia; Antonio Pellegrini; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

3.  Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1.

Authors:  Laure Sonnier; Gwenaëlle Le Pen; Andreas Hartmann; Jean-Charles Bizot; Fabrice Trovero; Marie-Odile Krebs; Alain Prochiantz
Journal:  J Neurosci       Date:  2007-01-31       Impact factor: 6.167

4.  Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.

Authors:  F D Dick; G De Palma; A Ahmadi; N W Scott; G J Prescott; J Bennett; S Semple; S Dick; C Counsell; P Mozzoni; N Haites; S Bezzina Wettinger; A Mutti; M Otelea; A Seaton; P Söderkvist; A Felice
Journal:  Occup Environ Med       Date:  2007-03-01       Impact factor: 4.402

5.  In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.

Authors:  ZaoDung Ling; Dave A Gayle; Shang Yong Ma; Jack W Lipton; Chong Wai Tong; Jau-Shyong Hong; Paul M Carvey
Journal:  Mov Disord       Date:  2002-01       Impact factor: 10.338

6.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

7.  Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

Authors:  Suzana Gispert; Domenico Del Turco; Lisa Garrett; Amy Chen; David J Bernard; John Hamm-Clement; Horst-Werner Korf; Thomas Deller; Heiko Braak; Georg Auburger; Robert L Nussbaum
Journal:  Mol Cell Neurosci       Date:  2003-10       Impact factor: 4.314

8.  Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.

Authors:  A Vaccari; P L Saba; S Ruiu; M Collu; P Devoto
Journal:  Toxicol Appl Pharmacol       Date:  1996-07       Impact factor: 4.219

9.  Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.

Authors:  Smitha Karunakaran; Latha Diwakar; Uzma Saeed; Varsha Agarwal; Sujanitha Ramakrishnan; Soumya Iyengar; Vijayalakshmi Ravindranath
Journal:  FASEB J       Date:  2007-03-16       Impact factor: 5.191

Review 10.  A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.

Authors:  Gloria E Meredith; Glenda M Halliday; Susan Totterdell
Journal:  Parkinsonism Relat Disord       Date:  2004-06       Impact factor: 4.891

View more
  66 in total

1.  Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson's disease.

Authors:  Annadurai Anandhan; Musthafa Mohamed Essa; Thamilarasan Manivasagam
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

Review 2.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

Review 3.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

4.  Cellular repair strategies in Parkinson's disease.

Authors:  Beate Winner; Daniela M Vogt-Weisenhorn; Chichung D Lie; Ingmar Blümcke; Jürgen Winkler
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 5.  Value of genetic models in understanding the cause and mechanisms of Parkinson's disease.

Authors:  Darren J Moore; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

6.  Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.

Authors:  Nanping Wu; Prasad R Joshi; Carlos Cepeda; Eliezer Masliah; Michael S Levine
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

7.  Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.

Authors:  Prachi Bajpai; Michelle C Sangar; Shilpee Singh; Weigang Tang; Seema Bansal; Goutam Chowdhury; Qian Cheng; Ji-Kang Fang; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

8.  Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.

Authors:  Zhongwang Yu; Xiaohui Xu; Zhenghua Xiang; Jianfeng Zhou; Zhaohuan Zhang; Chun Hu; Cheng He
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

9.  Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease.

Authors:  Torsten Falk; Shiling Zhang; Scott J Sherman
Journal:  Mol Neurodegener       Date:  2009-12-10       Impact factor: 14.195

Review 10.  Drosophila melanogaster as a model organism of brain diseases.

Authors:  Astrid Jeibmann; Werner Paulus
Journal:  Int J Mol Sci       Date:  2009-02-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.